Targeted cytokines for cancer immunotherapy

Immunologic Research

Volumn 21, Issue 2-3, 2000, Pages 279-288

  Lode, H N ^a   Reisfeld, R A ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Immunocytokines; Immunotherapy; Interleukin 2; Melanoma; Neuroblastoma; T cell memory

Indexed keywords

CYTOKINE; EPIDERMAL GROWTH FACTOR RECEPTOR; GANGLIOSIDE GD2; HYBRID PROTEIN; INTERLEUKIN 2; RECOMBINANT ANTIBODY; TUMOR VACCINE;

ARTICLE; BONE MARROW METASTASIS; CANCER IMMUNOTHERAPY; HELPER CELL; LIVER METASTASIS; LUNG METASTASIS; MELANOMA; MEMORY CELL; NEUROECTODERM TUMOR; NONHUMAN; PRIORITY JOURNAL; RECOMBINANT DNA TECHNOLOGY; SUPPRESSOR CELL; TARGET ORGAN; VACCINATION;

EID: 0033843152     PISSN: 0257277X     EISSN: None     Source Type: Journal    
DOI: 10.1385/IR:21:2-3:279     Document Type: Article

References (18)

1. Continuous cultures of fused cells secreting antibody of predefined specificity
2. Antibody-targeted interleukin-2 stimulates T-cell killing of autologous tumor cells
3. Imunocytokines: A new approach to immunotherapy of melanoma
4. T-cell-mediated eradication of murine metastatic melanoma induced by targeted interleukin-2 therapy
5. An antibody-interleukin-2 fusion protein overcomes tumor heterogeneity by induction of a cellular immune response
6. Long lived and transferable tumor immunity in mice after targeted interleukin-2 therapy
7. Clinical strategies for the treatment of neuroblastoma
8. A phase I study of human/mouse chimeric antiganglioside GD2 antibody ch14.18 in patients with neuroblastoma
9. Phase I/Ib trial of murine monoclonal antipGD2 antibody 14G2a plus IL2 in children with refractory neuroblastoma
10. Targeted interleukin-2 therapy of spontaneous neuroblastoma metastases to bone marrow
11. NK-cell mediated eradication of neuroblastoma metastases to bone marrow by targeted interleukin-2 therapy
12. Immunocytokines: A promising approach to cancer immunotherapy
13. Gene therapy with a single chain interleukin-12 fusion protein induces T-cell-dependent protective immunity in a syngeneic model of murine neuroblastoma
14. Tumor targeted interleukin-2 amplifies a cancer vaccine
15. Antigen presenting cells: Professionals and amateurs
16. Priming of tumor-specific T cells in the draining lymph nodes after immunization with interleukin 2-secreting tumor cells: Three consecutive stages may be required for successful tumor vaccination
17. Gene therapy for cancer: What have we done and where are we going